Phenotypic diversity drives paracrine drug tolerance

Considerable clinical successes have been achieved in cancer treatment since the introduction of targeted therapies. However, almost inevitably tumors develop therapy resistance, which limits durable clinical responses. Tumors are often heterogeneous, and as a result, therapy‐resistant cells are present even before the start of treatment. Resistance is commonly mediated via genetic changes. However, in this issue of EMBO Molecular Medicine, Smith et al (2017) report that phenotypic heterogeneity can contribute to resistance as well.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Phenotypic diversity drives paracrine drug tolerance ; volume:9 ; number:8 ; year:2017 ; pages:987-989 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; 9, Heft 8 (2017), 987-989 (gesamt 3)

Urheber
Kuilman, Thomas
Peeper, Daniel S.

DOI
10.15252/emmm.201707956
URN
urn:nbn:de:101:1-2022100108183289773045
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:34 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Kuilman, Thomas
  • Peeper, Daniel S.

Ähnliche Objekte (12)